ClinicalTrialsFinder
RecruitingNCT06953921

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

Sponsor

Sohag University

Enrollment

100 participants

Start Date

Mar 12, 2025

Study Type

OBSERVATIONAL

Conditions

Hepatic Encephalopathy

Summary

assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • patients aged >18 years.
  • Confirmed chronic liver disease (by imaging ,
  • liver function tests , and clinical history).
  • Diagnosed with hepatic encephalopathy based on clinical criteria.
  • Patients able to provide informed consent.

Exclusion Criteria5

  • Patients age less than 18 years old
  • Acute liver failure.
  • Chronic renal failure on dialysis.
  • Pregnant women.
  • Patients with active malignancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Sohag university hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06953921

Related Trials

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

NCT075213321 location

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

NCT060521761 location

TReatment for ImmUne Mediated PathopHysiology

NCT0486222124 locations

The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

NCT074180081 location

Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

NCT064253802 locations